Product Images Arformoterol Tartrate

The text appears to be a graph showing the mean change in FEV1 over time for a clinical trial at week 0, with time measured in hours postdose and the mean change from baseline FEV in liters.*

The text is describing a clinical trial involving a medication called arformoterol tartrate. The trial included 141 participants (ITT n=141) and was conducted to compare the effects of the medication to a placebo (ITT n=143). The baseline FEV (forced expiratory volume) for the placebo group was 1.20 L, but there is no data included for the baseline FEV of the group receiving arformoterol tartrate. The medication was administered twice a day at a dose of 15 micrograms.*

Arformoterol Tartrate Inhalation Solution is a prescription drug that comes in 2 mL vials, each containing 15 mg (expressed as an arformoterol) of arformoterol. The unused vials should be returned to and stored in the pouch after opening. The medication should be kept away from the reach of children. The unit dose vials should be protected from light and excessive heat. The medication must be used under the guidance of a physician and not recommended for others. This drug is manufactured by Cipla Ltd.*

Arformoterol Tartrate Inhalation Solution is a unit-dose vial containing 15 meg of arformoterol in a sterile, isotonic saline solution that should be kept away from light and excessive heat. The vials can be stored in a refrigerator or at room temperature for up to 6 weeks. Patients should discard the solution if it is not colorless and use only as directed by their physician. The product is manufactured by Cipla Ltd in India and distributed in the US by G USA, Inc.*

Arformoterol Tartrate Inhalation Solution is a medication that is used for inhalation through the mouth to help treat shortness of breath and wheezing caused by chronic obstructive pulmonary disease (COPD). It is available in 15-microgram capsules and is sold in sterile, unit-dose vials that can be stored at room temperature or refrigerated for up to six weeks. The medication includes 30 sterile, 2-milliliter unit-dose vials in a foil pouch. The potency of the medication is expressed as arformoterol and it is manufactured by Cipla. The medication is available for prescription-only in the NDC 69097-168-53 lot.*